logo
AAT Bioquest

GMP reductase 2 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
N~2~-(2,3-Dichlorophenyl)-N-[2-(Pyridin-4-Yl)-1,3-Benzoxazol-5-Yl]-L-AlaninamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamideKi5000.0 [1]
2-(4-Methoxyphenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamideKi5000.0 [1]
(2S)-N-[2-(4-Cyanophenyl)-1,3-benzoxazol-5-yl]-2-(2,3-difluoroanilino)propanamideKi5000.0 [1]
(2S)-N-[2-[4-(Aminomethyl)phenyl]-1,3-benzoxazol-5-yl]-2-(2,3-dichlorophenoxy)propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-[(4-methoxyphenyl)methyl]-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Difluorophenoxy)-N-[2-(4-hydroxyphenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Difluorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamideKi5000.0 [1]
2-[3-[5-[[(2S)-2-(2,3-Dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]phenoxy]acetic acidKi5000.0 [1]
(2S)-2-(2-Cyanophenoxy)-N-[2-(4-methoxyphenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(4-methoxyphenyl)-1,3-benzoxazol-5-yl]propanethioamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-[4-(tetrazol-1-yl)phenyl]-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-N-[2-(4-Cyanophenyl)-1,3-benzoxazol-5-yl]-2-(2-phenylmethoxyphenoxy)propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(3-oxo-2H-pyridin-4-yl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
4-[5-[[(2S)-2-(2,3-Dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]benzamideKi5000.0 [1]
Ethyl 2-[4-[5-[[(2S)-2-(2,3-dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]phenoxy]acetateKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-[4-(trifluoromethoxy)phenyl]-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
4-[5-[[(2S)-2-(2,3-Dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]benzoic acidKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(4-hydroxyphenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
Ethyl 2-[3-[5-[[(2S)-2-(2,3-dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]phenoxy]acetateKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(3-hydroxyphenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-[4-(2-oxo-3H-1,3,4-oxadiazol-5-yl)phenyl]-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-[4-(hydrazinecarbonyl)phenyl]-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(3-methoxypyridin-4-yl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2-Cyano-3-fluorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamideKi5000.0 [1]
Methyl 4-[5-[[(2S)-2-(2,3-dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]benzoateKi5000.0 [1]
(2S)-N-[2-(4-Cyanophenyl)-1,3-benzoxazol-5-yl]-2-(2,3,4-trifluorophenoxy)propanamideKi5000.0 [1]
(2S)-2-(2-Cyanophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamideKi5000.0 [1]
2-[4-[5-[[(2S)-2-(2,3-Dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]phenoxy]acetic acidKi5000.0 [1]
(2S)-N-[2-(4-Cyanophenyl)-1,3-benzoxazol-5-yl]-2-(2,3-dichloroanilino)propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]propanamideKi5000.0 [1]
Prop-2-ynyl 2-[4-[5-[[(2S)-2-(2,3-dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]phenoxy]acetateKi5000.0 [1]
(2S)-2-(2,3-Difluorophenoxy)-N-[2-(6-methoxypyridin-3-yl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-N-[2-(4-Cyanophenyl)-1,3-benzoxazol-5-yl]-2-(2-hydroxyphenoxy)propanamideKi5000.0 [1]
(2S)-2-(2,3-Difluorophenoxy)-N-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-[4-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-N-[2-(4-Cyanophenyl)-1,3-benzoxazol-5-yl]-2-(2,3-difluorophenoxy)propanamideKi5000.0 [1]
(2S)-N-[2-(4-Cyanophenyl)-1,3-benzoxazol-5-yl]-2-[(1-hydroxy-3H-2,1-benzoxaborol-7-yl)oxy]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(6-methoxypyridin-3-yl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Difluorophenoxy)-N-[2-(4-methoxyphenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-[4-[(E)-N'-hydroxycarbamimidoyl]phenyl]-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
4-[5-[[(2S)-2-(2,3-Dichlorophenoxy)propanoyl]amino]-1,3-benzoxazol-2-yl]-N-hydroxybenzamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(4-methoxyphenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-N-[2-(4-Cyanophenyl)-1,3-benzoxazol-5-yl]-2-(2,3-dichlorophenoxy)propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(1-oxidopyridin-1-ium-4-yl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-[2-(Aminomethyl)phenoxy]-N-[2-(4-methoxyphenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]
(2S)-2-(2,3-Dichlorophenoxy)-N-[2-(2-hydroxyphenyl)-1,3-benzoxazol-5-yl]propanamideKi5000.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ GMP reductase 2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/gmp-reductase-2-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ GMP reductase 2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/gmp-reductase-2-inhibitors-ic50-ki.
BibTeXEndNoteRefMan